相关实验视频

Updated: Sep 18, 2025

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

与对照组相比,Gaucher 病携带者中的原发性帕金森特征与对照组相比

Michal Becker-Cohen^1,2, Ari Zimran^1,3,4, Tama Dinur¹

¹Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.

Life (Basel, Switzerland)

|June 26, 2025

概括

氏病携带者没有比对照群表现出更多的前发性帕金森病 (PD) 症状. 然而,在携带者中观察到不同的认知和运动模式,年龄和家族史影响了结果,这表明潜在的早期干预目标.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
神经学神经学

背景情况:

戈舍氏病携带者患帕金森病 (PD) 的风险较高.
在神经保护性干预中,早期发现前发性PD至关重要.
目前正在研究GBA1变异携带者,以确定PD风险.

研究的目的:

为了在GBA1携带者和对照者中比较非侵入性prodromal PD测试.
为了确定与异常的前性PD测试相关的风险因素.
分析GBA1携带者与对照者的认知,运动和非运动模式.

主要方法:

在164个GBA1携带者和49个对照人群中比较prodromal PD测试异常.
对异常测试 (≥1或≥20%异常) 的风险因素分析.
认知,运动和非运动模式的主要组成部分分析;年龄,家族史和性别影响的评估.

主要成果:

在GBA1携带者和对照者之间,异常prodromal PD测试的频率没有显著差异.
异常测试频率 (≥20%) 主要与年龄有关.
在GBA1携带者中发现了明显的认知运动功能障碍模式,受年龄,家族史和性别的影响.

结论:

虽然prodromal PD测试异常没有差异,但GBA1载体的独特功能障碍模式需要进一步调查.
年龄和家族病史是影响携带者检测结果的重要因素.
纵向研究对于了解GBA1载体的PD进展和制定有针对性的干预措施至关重要.

关键词:

在 GBA1 运营商.戈舍氏病是戈舍氏病的一种疾病.帕金森病是帕金森氏症的一种疾病.西德兰斯基综合征是什么意思主要组件分析的主要组件分析发生性帕金森病.

更多相关视频

Technique for Intranasal Administration of α-Synuclein Aggregates

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...